Area of research
Pulmonary and Respiratory Medicine · Oncology
Research interest
Research interests include Colorectal Cancer Treatments and Studies, Lung Cancer Treatments and Mutations, Cancer Genomics and Diagnostics, and Gastric Cancer Management and Outcomes.
PCSK9 drives sterol-dependent metastatic organ choice in pancreatic cancer
Molecular hyperselection for optimal choice of first-line targeted therapy independent of primary tumor sidedness: An exploratory analysis of the randomized FIRE-3 study performed in RAS wild-type metastatic colorectal cancer
Impact of sex on efficacy and safety of 1st-line treatment with FOLFIRI plus cetuximab or bevacizumab in RAS/BRAF wildtype metastatic colorectal cancer – A subgroup analysis of the FIRE-3 (AIO KRK-0306) trial
Precision Oncology in Rare Endocrine and Neuroendocrine Neoplasms: Experiences and Challenges of the CCCMunichLMU Molecular Tumor Board
Evaluation of circulating tumor <scp>DNA</scp> as a prognostic and predictive biomarker in <i>BRAF</i> <scp>V600E</scp> mutated colorectal cancer—results from the <scp>FIRE</scp> ‐4.5 study
Patient eligibility for trials with imaging response assessment at the time of molecular tumor board presentation